Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected healthcare institutions in Colombia.

"Declarations Ethics approval and consent to participateThe Ethics Committee of the participants HMOs approved this research. Competing interestsMónica María Rojas, Juan Camilo Urrego, Claudia Catalina Beltrán, Jaime Enrique Ruíz, Adriana Velásquez, Juan Carlos Orengo and Adolfo Pinzón are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA. Nelson Alvis, Fernando Salcedo, and Maria Carrasquilla from Grupo ALZAK received financial support from MSD. Martin Romero and Lina Gómez from Grupo Proyectame also received financial support from MSD. Competing interests Mónica María Rojas, Juan Camilo Urrego, Claudia Catalina Beltrán, Jaime Enrique Ruíz, Adriana Velásquez, Juan Carlos Orengo and Adolfo Pinzón are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA. Nelson Alvis, Fernando Salcedo, and Maria Carrasquilla from Grupo ALZAK received financial support from MSD. Martin Romero and Lina Gómez from Grupo Proyectame also received financial support from MSD."

"Funding Funding for this research was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Although the sponsors formally reviewed a penultimate draft, the opinions expressed are those of the authors and may not necessarily reflect those of the sponsors. All coauthors approved the final version of the manuscript."